资讯

Business News News India CSIR to begin clinical trial of drugs favipiravir, phytopharmaceutical for Covid-19 treatment More First Published: 8 May 2020, 03:42 PM IST ...
Frutarom Health BU, Switzerland, announces the launch of EFLA®pharm, a flagship proprietary product line comprised of both phytopharmaceutical ingredients and pharma flavors.
Click here IPC set to develop monograph of phytopharmaceutical ingredients ...
Ad hoc-Mitteilungen: Nachrichten»Frutarom Health Increases Phytopharmaceutical Capacity Push Mitteilungen PR Newswire 06.02.2017 10:02 Uhr 158 Leser Artikel bewerten: (0) ...
Frutarom Health BU reports it will strengthen focus on its phytopharmaceutical business in 2017. This follows the 2016 acquisition of Extrakt Chemie GmbH & Co.KG, in Stadhagen, near Hannover ...
Commenting on the partnership, Abhishek Mohan, Founder & CEO, HempStreet, said, “We are very pleased to enter this partnership with Yotam and the team at Gynica, who are a cutting edge biotech ...
NEW DELHI: Sun Pharmaceutical Industries Ltd on Friday said it has commenced phase-II clinical trial of AQCH, a phytopharmaceutical or a plant derived drug, for the treatment of covid-19.
The Drug Controller General of India (DGCI) has given green signal to the Council for Scientific and Industrial Research (CSIR) to conduct clinical trial on drugs - 'favipiravir' and ...
Union government notified in the gazette that phytopharmaceutical drugs will be inserted under a separate definition in the Drugs & Cosmetics (Eighth Amendment) Rules, 2015. The inclusion of ...
Amman – Jordan: UNIDO and a coalition of public and private partners, including Changelabs, announce the launch of Jordan’s first accelerator targeting natural cosmetics, fashion, and ...